FRESENIUS SE & CO KGAA (FRE.DE) Stock Price & Overview

FRA:FRE • DE0005785604

47.14 EUR
+0.41 (+0.88%)
Last: Mar 9, 2026, 07:00 PM

The current stock price of FRE.DE is 47.14 EUR. Today FRE.DE is up by 0.88%. In the past month the price decreased by -5.76%. In the past year, price increased by 18.86%.

FRE.DE Key Statistics

52-Week Range31.6 - 52.96
Current FRE.DE stock price positioned within its 52-week range.
1-Month Range45.68 - 52.96
Current FRE.DE stock price positioned within its 1-month range.
Market Cap
26.551B
P/E
14.73
Fwd P/E
12.68
EPS (TTM)
3.20
Dividend Yield
2.26%

FRE.DE Stock Performance

Today
+0.88%
1 Week
-6.25%
1 Month
-5.76%
3 Months
-0.88%
Longer-term
6 Months +1.29%
1 Year +18.86%
2 Years +88.56%
3 Years +89.70%
5 Years +24.12%
10 Years -26.58%

FRE.DE Stock Chart

FRESENIUS SE & CO KGAA / FRE Daily stock chart

FRE.DE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to FRE.DE. When comparing the yearly performance of all stocks, FRE.DE turns out to be only a medium performer in the overall market: it outperformed 69.9% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
FRE.DE Full Technical Analysis Report

FRE.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE. Both the profitability and the financial health of FRE.DE get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
FRE.DE Full Fundamental Analysis Report

FRE.DE Earnings

On February 25, 2026 FRE.DE reported an EPS of 0.63 and a revenue of 5.96B. The company missed EPS expectations (-28.85% surprise) and missed revenue expectations (-1.28% surprise).

Next Earnings DateMay 6, 2026
Last Earnings DateFeb 25, 2026
PeriodQ4 / 2025
EPS Reported€0.63
Revenue Reported5.961B
EPS Surprise -28.85%
Revenue Surprise -1.28%
FRE.DE Earnings History

FRE.DE Forecast & Estimates

23 analysts have analysed FRE.DE and the average price target is 56.38 EUR. This implies a price increase of 19.59% is expected in the next year compared to the current price of 47.14.

For the next year, analysts expect an EPS growth of 16.18% and a revenue growth 4.95% for FRE.DE


Analysts
Analysts85.22
Price Target56.38 (19.6%)
EPS Next Y16.18%
Revenue Next Year4.95%
FRE.DE Forecast & Estimates

FRE.DE Groups

Sector & Classification

FRE.DE Financial Highlights

Over the last trailing twelve months FRE.DE reported a non-GAAP Earnings per Share(EPS) of 3.2. The EPS increased by 6.31% compared to the year before.


Income Statements
Revenue(TTM)22.68B
Net Income(TTM)1.14B
Industry RankSector Rank
PM (TTM) 5.11%
ROA 2.69%
ROE 6.14%
Debt/Equity 0.61
Chartmill High Growth Momentum
EPS Q2Q%-25%
Sales Q2Q%5.88%
EPS 1Y (TTM)6.31%
Revenue 1Y (TTM)3.87%
FRE.DE financials

FRE.DE Ownership

Ownership
Inst Owners45.33%
Shares563.24M
Float411.13M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
FRE.DE Ownership

About FRE.DE

Company Profile

FRE logo image Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 177,356 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.

Company Info

FRESENIUS SE & CO KGAA

Else-Kroener-Str. 1

BAD HOMBURG HESSEN DE

Employees: 176486

FRE Company Website

FRE Investor Relations

Phone: 4961726080

FRESENIUS SE & CO KGAA / FRE.DE FAQ

What does FRE do?

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 177,356 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.


What is the current price of FRE stock?

The current stock price of FRE.DE is 47.14 EUR. The price increased by 0.88% in the last trading session.


What is the dividend status of FRESENIUS SE & CO KGAA?

FRESENIUS SE & CO KGAA (FRE.DE) has a dividend yield of 2.26%. The yearly dividend amount is currently 0.


How is the ChartMill rating for FRESENIUS SE & CO KGAA?

FRE.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


What is the analyst forecast for FRE.DE stock?

23 analysts have analysed FRE.DE and the average price target is 56.38 EUR. This implies a price increase of 19.59% is expected in the next year compared to the current price of 47.14.


What sector and industry does FRESENIUS SE & CO KGAA belong to?

FRESENIUS SE & CO KGAA (FRE.DE) operates in the Health Care sector and the Health Care Providers & Services industry.